Terns Pharmaceuticals to Participate in Upcoming September Investor Conferences
06 September 2023 - 6:05AM
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq:
TERN), a clinical-stage biopharmaceutical company developing a
portfolio of small-molecule product candidates to address serious
diseases, including oncology, non-alcoholic steatohepatitis (NASH)
and obesity, today announced that members of senior management will
be participating in the following upcoming investor conferences in
September.
2023 Wells Fargo Healthcare Conference
Location: Encore Boston Harbor, Boston, MAFormat: 1x1 Investor
Meetings on Thursday, September 7
H.C. Wainwright 25th Annual Global Investment
ConferenceLocation: Lotte New York Palace Hotel, New York,
NY Format: Fireside Chat on Monday, September 11 at 11:30am ET
A live webcast of the Fireside Chat will be available on the
investor relations page of the Terns Pharmaceuticals website at
http://ir.ternspharma.com. A replay of the webcasts will be
archived on Terns’ website for at least 30 days following the
presentations.
About Terns PharmaceuticalsTerns
Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company
developing a portfolio of small-molecule product candidates to
address serious diseases, including oncology, NASH and obesity.
Terns’ pipeline includes two clinical stage development programs
including an allosteric BCR-ABL inhibitor and a THR-β agonist (+/-
an FXR agonist), and preclinical small-molecule GLP-1 receptor
agonist and GIPR modulator programs. For more information, please
visit: www.ternspharma.com.
Contacts for Terns
InvestorsMark
Vignolainvestors@ternspharma.com
MediaJenna UrbanBerry & Company Public
Relationsmedia@ternspharma.com
Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Jul 2023 to Jul 2024